限制性人细胞毒性T淋巴细胞 (CTL) 表位蛋白多肽11-20/160040-04-0/HPV16-E711-20 epitope

Product Name：HPV16-E711-20 epitope

CAS No.： 160040-04-0

Synonyms：限制性人细胞毒性T淋巴细胞 (CTL) 表位蛋白多肽11-20

Catalog No.：218P961

Brand：HongTide（上海鸿肽生物）

Description：HPV16-E711-20 epitope是一种HLA-A*0201 限制性人细胞毒性T淋巴细胞 (CTL) 表位的 HPV16 E7 蛋白多肽，序列中含有10个氨基酸，在体外显示了与 HLA-A2 的高亲和力结合。HPV16 CTL 表位可能是开发有效肽基抗肿瘤疫苗的良好候选。

HPV16-E711-20 epitope is a HPV16 E7 protein polypeptide with HLA-A * 0201 restricted human cytotoxic T lymphocyte (CTL) epitope. The sequence contains 10 amino acids and has shown high affinity binding to HLA-A2 in vitro. The HPV16 CTL epitope may be a good candidate for developing effective peptide based anti-tumor vaccines.

Purity (HPLC) ≥98.0%

Single impurity≤2%

Peptide content≥75.0%

Amino Acid Composition≤±15%

Bacterial Endotoxins≤50EU/mg

Solubility：H₂O/DMSO

Vacuum-packed with aluminum foil bag or transparent bag.Various weights can be packed according to your requirements.

Storage:Cool dry place( Store at -20°C, away from the light)

Remark:For Research Use Only. Not for human use.

订购联系方式：

上海鸿肽生物科技有限公司

手机： +86-18018095145 （同微信号）

QQ: 3259098395

邮箱：sales1@hongtide.com